Alyeska Investment Group L.P. Purchases 450,000 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Alyeska Investment Group L.P. boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 159.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 732,948 shares of the company's stock after acquiring an additional 450,000 shares during the quarter. Alyeska Investment Group L.P. owned 0.43% of Option Care Health worth $17,004,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP raised its stake in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after acquiring an additional 591,042 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after acquiring an additional 278,158 shares during the period. Finally, Norges Bank acquired a new stake in shares of Option Care Health in the 4th quarter valued at $60,219,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Up 0.4 %

OPCH stock traded up $0.14 during midday trading on Friday, reaching $31.84. The company's stock had a trading volume of 1,566,842 shares, compared to its average volume of 1,843,451. The business's 50-day simple moving average is $33.24 and its 200-day simple moving average is $28.89. The stock has a market cap of $5.21 billion, a PE ratio of 26.76, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the previous year, the firm earned $0.26 earnings per share. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.64% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of several analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.